Life Sciences Tools and Services
Company Overview of inVentiv Health Inc.
inVentiv Health Inc. provides value-added services to the pharmaceutical and life sciences industries in the U.S. and internationally. The company supports a range of clinical development, communications, and commercialization activities critical to developing new drug products and medical devices. Its inVentiv Clinical segment provides services related to permanent placement, clinical staffing, data collection and management, and functional outsourcing. The inVentiv Communications segment furnishes advertising, communications, and other functionally related services. InVentiv Commercial provides commercialization services, including outsourced product commercialization programs; patient sup...
1 Van de Graaff Drive
Burlington, MA 01803
Founded in 1996
Key Executives for inVentiv Health Inc.
Chairman and Chief Executive Officer
President of Smith Hanley Companies and Chief Executive Officer of Smith Hanley Companies
Chief Executive Officer of i3 Organization
Chief Executive Officer of Campbell Alliance
Compensation as of Fiscal Year 2014.
inVentiv Health Inc. Key Developments
Biohaven Pharmaceutical Holding Company Limited Enters into Agreement with inVentiv Health
Apr 1 15
Portage Biotech Inc. announced that Biohaven Pharmaceutical Holding Company Limited has entered into an agreement with inVentiv Health for the operational execution of Biohaven's first clinical trial with their lead compound (BHV-0223).
inVentiv Health Inc. Presents at BIO-Europe Spring 2015, Mar-09-2015 02:45 PM
Mar 5 15
inVentiv Health Inc. Presents at BIO-Europe Spring 2015, Mar-09-2015 02:45 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France. Speakers: Mark Archer, Executive VP, Global Head of Business Development.
inVentiv Health Plans to Open New Phase I/IIA Clinic in Miami, Florida
Feb 13 15
inVentiv Health announced plans to open a new Phase I/IIA clinic in Miami, expanding its Phase I clinical services to the US. The clinic will facilitate patient access and help expedite progression to Proof of Concept (PoC) for pharmaceutical and biotech clients who are seeking access to broad patient demographics. The new clinic, which expects to begin running studies in the second half of 2015, will complement inVentiv Health's existing clinical facility in Quebec City, Canada. The 65-bed Miami clinic, located in the University of Miami Life Science and Technology Park, will focus on complex studies including first-in-human Phase I, Phase I-in-patient and other multifaceted Phase I trials such as drug-drug interaction, biosimilar, first-to-file and 505b2 trials. Clients also should benefit from inVentiv Health's innovative approach to clinical trial recruitment, as well as additional capabilities that support the full product life-cycle from early phase development through comprehensive launch and commercialization.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 12, 2014
July 15, 2014